Deutsch English Français

Contact

EP2780375

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP2780375

EP2780375 - BINDING MOLECULES FOR BCMA AND CD3 [Right-click to bookmark this link]
Status	Patent revoked Status updated on 31.05.2024 Database last updated on 03.04.2025
Former	The patent has been granted Status updated on 09.08.2019
Former	Grant of patent is intended Status updated on 17.03.2019
Former	Examination is in progress Status updated on 29.01.2019
Former	Grant of patent is intended Status updated on 23.09.2018
Former	Examination is in progress Status updated on 09.11.2016
Most recent event Tooltip	31.05.2024	Revocation of patent	published on 03.07.2024 [2024/27]
Applicant(s)	For all designated states Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 München / DE
	For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320-1799 / US
	[2017/23]
Former [2014/39]	For all designated states Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 München / DE
	For all designated states Boehringer Ingelheim International GmbH Binger Strasse 173 55216 Ingelheim am Rhein / DE
Inventor(s)	01 / KUFER, Peter c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	02 / RAUM, Tobias c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	03 / HOFFMANN, Patrick c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	04 / KISCHEL, Roman c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	05 / LUTTERBUESE, Ralf c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	06 / RAU, Doris c/o Amgen Research (Munich) GmbH Staffelseestr. 2 81477 Munich / DE
	07 / ADAM, Paul c/o Boehringer Ingelheim GmbH Corporate Patents Binger Str. 173 55216 Ingelheim am Rhein / DE
	08 / BORGES, Eric c/o Boehringer Ingelheim GmbH Corporate Patents Binger Str. 173 55216 Ingelheim am Rhein / DE
	09 / HEBEIS, Barbara c/o Boehringer Ingelheim GmbH Corporate Patents Binger Str. 173 55216 Ingelheim am Rhein / DE
	10 / HIPP, Susanne c/o Boehringer Ingelheim GmbH Corporate Patents Binger Str. 173 55216 Ingelheim am Rhein / DE
	[2014/39]
Representative(s)	Dörries, Hans Ulrich, et al df-mp Patentanwälte Rechtsanwälte PartG mbB Theatinerstraße 16 80333 München / DE
	[N/P]
Former [2019/37]	Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB Ganghoferstraße 68 B 80339 München / DE
Former [2014/39]	Schiweck, Weinzierl & Koch European Patent Attorneys Landsberger Straße 98 80339 München / DE
Application number, filing date	12805432.7	15.11.2012
	[2019/37]
	WO2012EP72699
Priority number, date	US201161560144P	15.11.2011 Original published format: US 201161560144 P
	US201161560149P	15.11.2011 Original published format: US 201161560149 P
	US201161560162P	15.11.2011 Original published format: US 201161560162 P
	US201161560178P	15.11.2011 Original published format: US 201161560178 P
	US201161560183P	15.11.2011 Original published format: US 201161560183 P
	US201261651486P	24.05.2012 Original published format: US 201261651486 P
	US201261651474P	24.05.2012 Original published format: US 201261651474 P
	[2014/39]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2013072406
	Date:	23.05.2013
	Language:	EN
	[2013/21]
	Type:	A1 Application with search report
	No.:	EP2780375
	Date:	24.09.2014
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 23.05.2013 takes the place of the publication of the European patent application.
	[2014/39]
	Type:	B1 Patent specification
	No.:	EP2780375
	Date:	11.09.2019
	Language:	EN
	[2019/37]
Search report(s)	International search report - published on:	EP	23.05.2013
Classification	IPC:	C07K16/28, A61K39/395, A61P35/02, A61P37/00	[2014/39]
	CPC:	C07K16/468 (EP,US); C07K16/2809 (EP,KR,US); A61K39/0005 (US); A61P17/00 (EP); A61P19/00 (EP); A61P3/00 (EP); (+) A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP); A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP); A61P7/00 (EP); C07K14/70578 (EP,US); C07K16/2875 (US); C07K16/2878 (EP,KR,US); A61K2039/505 (EP,US); A61K2039/575 (US); C07K2317/31 (EP,KR,US); C07K2317/33 (EP,US); C07K2317/34 (EP,KR,US); C07K2317/56 (EP,US); C07K2317/565 (EP,US); C07K2317/622 (EP,US); C07K2317/73 (EP,US); C07K2317/92 (EP,US); C07K2317/94 (EP,US); C07K2319/00 (EP,US); C07K2319/21 (EP,US); C07K2319/30 (EP,US); C07K2319/31 (EP,US); C07K2319/43 (EP,US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/39]
Extension states	BA	10.06.2014
	ME	10.06.2014
Title	German:	BINDEMOLEKÜLE FÜR BCMA UND CD3	[2014/39]
	English:	BINDING MOLECULES FOR BCMA AND CD3	[2014/39]
	French:	MOLÉCULES DE LIAISON POUR BCMA ET CD3	[2014/39]
Entry into regional phase	10.06.2014	National basic fee paid
	10.06.2014	Designation fee(s) paid
	10.06.2014	Examination fee paid
Examination procedure	10.06.2014	Amendment by applicant (claims and/or description)
	10.06.2014	Examination requested [2014/39]
	07.10.2015	Despatch of a communication from the examining division (Time limit: M06)
	13.04.2016	Reply to a communication from the examining division
	31.10.2016	Despatch of a communication from the examining division (Time limit: M06)
	10.05.2017	Reply to a communication from the examining division
	25.01.2018	Despatch of a communication from the examining division (Time limit: M06)
	09.07.2018	Reply to a communication from the examining division
	24.09.2018	Communication of intention to grant the patent
	25.01.2019	Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
	18.03.2019	Communication of intention to grant the patent
	25.07.2019	Fee for grant paid
	25.07.2019	Fee for publishing/printing paid
	25.07.2019	Receipt of the translation of the claim(s)
Divisional application(s)	EP19196304.0 / EP3611193
	EP24219338.1 / EP4512481
	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.10.2015
Opposition(s)	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 02.10.2023 WITHDRAWN Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 12.12.2022 WITHDRAWN Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		[2023/45]
	Former [2023/29]
	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 15.06.2020 ADMISSIBLE Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 12.12.2022 WITHDRAWN Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2023/03]
	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 15.06.2020 ADMISSIBLE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 12.12.2022 WITHDRAWN Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2022/30]
	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative König Szynka Tilmann von Renesse Patentanwälte Partnerschaft mbB Düsseldorf, et al, et al Mönchenwerter Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 15.06.2020 ADMISSIBLE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 15.06.2020 ADMISSIBLE Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2021/37]
	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 15.06.2020 ADMISSIBLE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 15.06.2020 ADMISSIBLE Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2020/30]
	Opponent(s)	01 06.03.2020 15.06.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 15.06.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Duffield, Stephen Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 15.06.2020 ADMISSIBLE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 15.06.2020 ADMISSIBLE Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
		05 11.06.2020 15.06.2020 ADMISSIBLE Regeneron Pharmaceuticals, Inc. 777 Old Saw Mill River Road Tarrytown NY 10591 / US Opponent's representative Wise, Daniel Joseph Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		06 11.06.2020 15.06.2020 ADMISSIBLE James Poole Limited One Southampton Row London WC1B 5HA / GB Opponent's representative Adams, Harvey Vaughan John Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		07 11.06.2020 15.06.2020 ADMISSIBLE Mathys & Squire LLP The Shard 32 London Bridge Street London SE1 9SG / GB Opponent's representative Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB
		08 12.06.2020 16.06.2020 ADMISSIBLE Sanofi 54 Rue La Boétie 75008 Paris / FR Opponent's representative Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE
	Former [2020/29]
	Opponent(s)	01 06.03.2020 ADMISSIBLE AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 ADMISSIBLE Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Duffield, Stephen Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 ADMISSIBLE Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
		04 10.06.2020 Teneobio, Inc. 7999 Gateway Blvd. Newark CA 94560 / US
	Former [2020/24]
	Opponent(s)	01 06.03.2020 AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Duffield, Stephen Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
		03 04.05.2020 Pfizer Inc. 235 East 42nd Street New York, NY 10017 / US Opponent's representative Pfizer European Patent Department 23-25 avenue du Docteur Lannelongue 75668 Paris Cedex 14 / FR
	Former [2020/22]
	Opponent(s)	01 06.03.2020 AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
		02 14.04.2020 Janssen Biotech, Inc. 800/850 Ridgeview Drive Horsham PA 19044 / US Opponent's representative Duffield, Stephen Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB
	Former [2020/17]
	Opponent(s)	01 06.03.2020 AbbVie Inc. 1 North Waukegan Road North Chicago, IL 60064 / US Opponent's representative Roth, Carla, et al, et al König-Szynka-Tilmann-von Renesse Patentanwälte Partnerschaft mbB Mönchenwerther Straße 11 40545 Düsseldorf / DE
	21.07.2020	Invitation to proprietor to file observations on the notice of opposition
	01.02.2021	Reply of patent proprietor to notice(s) of opposition
	24.04.2023	Date of oral proceedings
	05.07.2023	Despatch of minutes of oral proceedings
	05.07.2023	Despatch of communication that the patent will be revoked
	22.05.2024	Legal effect of revocation of patent [2024/27]
Appeal following opposition	12.09.2023	Appeal received No. T1648/23
	12.09.2023	Payment of appeal fee
	15.11.2023	Statement of grounds filed
	22.05.2024	Result of appeal procedure: REVOCATION OF PATENT AT PROPRIETOR'S REQUEST
	24.05.2024	Despatch of the decision of the Board of Appeal
	22.05.2024	Date of oral proceedings
Fees paid	Renewal fee
	25.11.2014	Renewal fee patent year 03
	24.11.2015	Renewal fee patent year 04
	23.11.2016	Renewal fee patent year 05
	24.11.2017	Renewal fee patent year 06
	14.11.2018	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]WO0187977 (AMGEN INC [US]);
		[XDY]WO02066516 (ZYMOGENETICS INC [US]);
		[YA]WO2004106383 (MICROMET AG [DE], et al);
		[XI]WO2009132058 (ZYMOGENETICS INC [US], et al);
		[XPI]WO2012066058 (BOEHRINGER INGELHEIM INT [DE], et al);
	by applicant	US4485045
		US4544545
		EP0171496
		EP0173494
		EP0183070
		GB2177096
		EP0239400
		EP0244234
		US4816567
		US4816397
		US4946778
		EP0402226
		US5013556
		US5223409
		US5225539
		US5565332
		WO9634096
		WO9633735
		US5585089
		US5648260
		WO9738731
		US5693761
		US5693762
		WO9852976
		US5859205
		WO9954440
		WO0034317
		EP1019141
		US6300064
		US6407213
		WO02066516
		US2003070185
		WO2007042261
		WO2008119567
	Opposition	WO2009132058
		WO2010104949
		WO2012066058
		EP2780374
		WO02066516
		WO2004106383
		WO2007042261
		WO2008119565
		WO2008119566
		WO2008119567
		WO2010037835
		WO2010037836
		WO2010037837
		WO2010037838
		US9150664
		US9340621
		WO0124811
		US2007212733
		WO2013072406
		WO2014072406
		WO0187977
		EP2640750
		WO0040716
		WO0112812
		WO2005040220
		WO2005061547
		EP1223964
		EP1210425
		EP1806143

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.32; 35p